CompletedNCT05409846

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies

Studying Fabry disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidade do Porto
Principal Investigator
Elisabete Martins, MD, PhD
Universidade do Porto
Intervention
Alfa-galactosidase activity and genetic testing for Fabry diagnosis(diagnostic_test)
Enrollment
409 enrolled
Eligibility
30 years · All sexes
Timeline
2022 – 2025

Study locations (11)

Collaborators

Centro Hospitalar De São João, E.P.E. · Hospital Pedro Hispano · Centro Hospitalar do Tâmega e Sousa, Hospital Padre Américo · Hospital da Luz Lisboa, Portugal · Centro Hospitalar De Trás-Os-Montes E Alto Douro, E.P.E. · Centro Hospitalar Universitário Lisboa Norte, EPE., Hospital de Santa Maria · Centro Hospitalar de Entre Douro e Vouga, E.P.E., Hospital São Sebastião · Centro Hospitalar Universitário de Coimbra · Centro Hospitalar de Vila Nova de Gaia e Espinho, E.P.E. · Centro Hospitalar Universitário de Santo António · Centro de Investigação em Tecnologias e Serviços de Saúde · Rede de Investigação em Saúde

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05409846 on ClinicalTrials.gov

Other trials for Fabry disease

Additional recruiting or active studies for the same condition.

See all trials for Fabry disease →

← Back to all trials